Product Name :
Fluvastatin Sodium
Description:
Fluvastatin sodium is an HMG-CoA reductase inhibitor used to lower cholesterol and lipid levels. It may inhibit RhoA. It also prevents viral replication of hepatitis C, decreases platelet activation, scavenges hydroxyl radicals, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells, and improves left ventricular function and prevents fibrosis in cardiac distress models.
CAS:
93957-55-2
Molecular Weight:
434.46
Formula:
C24H26FNNaO4
Chemical Name:
(3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid sodium
Smiles :
[Na].CC(C)N1C(/C=C/[C@H](O)C[C@H](O)CC(O)=O)=C(C2=CC=C(F)C=C2)C2=CC=CC=C12 |^1:0|
InChiKey:
CUOKYGJQSIKNFS-RPQBTBOMSA-N
InChi :
InChI=1S/C24H26FNO4.Na/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);/b12-11+;/t18-,19-;/m0./s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Fluvastatin sodium is an HMG-CoA reductase inhibitor used to lower cholesterol and lipid levels.{{Voxilaprevir} medchemexpress|{Voxilaprevir} Anti-infection|{Voxilaprevir} Protocol|{Voxilaprevir} In Vitro|{Voxilaprevir} custom synthesis|{Voxilaprevir} Epigenetics} It may inhibit RhoA.{{Isorhamnetin} site|{Isorhamnetin} MAPK/ERK Pathway|{Isorhamnetin} Purity & Documentation|{Isorhamnetin} In Vivo|{Isorhamnetin} custom synthesis|{Isorhamnetin} Epigenetic Reader Domain} It also prevents viral replication of hepatitis C, decreases platelet activation, scavenges hydroxyl radicals, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells, and improves left ventricular function and prevents fibrosis in cardiac distress models.|Product information|CAS Number: 93957-55-2|Molecular Weight: 434.46|Formula: C24H26FNNaO4|Chemical Name: (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid sodium|Smiles: [Na].PMID:23557924 CC(C)N1C(/C=C/[C@H](O)C[C@H](O)CC(O)=O)=C(C2=CC=C(F)C=C2)C2=CC=CC=C12 |^1:0||InChiKey: CUOKYGJQSIKNFS-RPQBTBOMSA-N|InChi: InChI=1S/C24H26FNO4.Na/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);/b12-11+;/t18-,19-;/m0./s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|